CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL โ including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor โ provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
Unlock the market timeline & signal feed
New Product & Tech activity โ 1 fresh signal just appeared.
The order this company entered each market โ oldest to newest
Swiss Nephrology Congress โ Congratulations to the winners of the 2025 Poster Awards
Associate Director, Global Knowledge Management
Sign up to see the full signal feed
How CSL's international expansion compares to its competitors
CSLYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 CSLYou | 26 | 0 | -3% | 544 | 38 |
Scaling fast โ 860 roles opened in the last 90 days, up 331% vs the prior period. Support-led and concentrated in United States.
Glattbrugg, Zurich, Switzerland ยท 2d ago
Associate Director, Global Knowledge Management
Marburg an der Lahn, Hesse, Germany ยท 2d ago
Senior Accounts Payable Specialist (m/w/d)
Marburg an der Lahn, Hesse, Germany ยท 2d ago
Manager (m/w/d) Environmental, Health & Safety
20 technologies detected across the stack.
6 active campaigns across 17 markets.
Ended
Ended
Ended9 mentions in the last 90 days.
ASX 200 dropped 0.4% as Middle East conflicts pushed oil prices higher and bond yields surged to 2011 highs, pressuring consumer and tech stocks.
ASX 200 up 0.6% as BHP hits record high of $68.22. Healthcare leads with Ansell up 7%, CSL up 2.5%. Coles reports $1.1B profit, Aurizon announces $250M buyback.
BHP and Rio Tinto shift focus to copper, lithium, and critical minerals, betting on future demand. CSL and AGL forecast stronger earnings. Market tests 9,200 support level amid reporting season volatility.
Unlock verified emails & direct dials
Free ยท No credit card needed
Quick answers about CSL's business, markets, and growth signals.
โWe reach accounts the week they land in-market โ not the quarter after.โ
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
ยฉ 2026 Pubrio. All rights reserved.
